1. Ponatinib miRNA İfadelerini Düzenleyerek Meme Kanseri Hücrelerini Hedefler
   Çağla KAYABAŞI et al, 2021, Uludağ Üniversitesi Tıp Fakültesi Dergisi CrossRef
2. Lnc-uc.147 Is Associated with Disease Stage of Liver, Gastric, and Renal Cancer
   Ana Carolina Rodrigues et al, 2023, Biomolecules CrossRef
3. High TEAD4 Expression is Associated With Aggressive Clear Cell Renal Cell Carcinoma, Regardless of YAP1 Expression
   Min A. Park et al, 2023, Applied Immunohistochemistry & Molecular Morphology CrossRef
4. A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma
   Jingjing Zhang et al, 2022, Life Sciences CrossRef
5. A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma
   Xiaoxia Gong et al, 2022, Frontiers in Pharmacology CrossRef
6. Histone H4 asymmetrically dimethylated at arginine 3 (H4R3me2a), a mark of super-enhancers
   Sadhana R.N. Sudhakar et al, 2024, Biochemistry and Cell Biology CrossRef
7. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers
   Tengfei Li et al, 2022, Biomedicine & Pharmacotherapy CrossRef
8. Microtubule affinity regulating kinase 4: A potential drug target from cancers to neurodegenerative diseases
   Narendran Annadurai et al, 2022, Protein Kinase Inhibitors CrossRef
9. TEAD4 predicts poor prognosis and transcriptionally targets PLAGL2 in serous ovarian cancer
   Xin Tong et al, 2023, Human Cell CrossRef
10. From the Matrix to the Nucleus and Back: Mechanobiology in the Light of Health, Pathologies, and Regeneration of Oral Periodontal Tissues
    Martin Philipp Dieterle et al, 2021, Biomolecules CrossRef
11. A three-gene signature reveals changes in the tumor immune microenvironment in the progression from NAFLD to HCC
    Lijuan Liu et al, 2023, Scientific Reports CrossRef
12. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review)
    Taruna Arora et al, 2022, Oncology Reports CrossRef
13. PKNOX1 acts as a transcription factor of DHH and promotes the progression of stomach adenocarcinoma by regulating the Hedgehog signalling pathway
    Bing Liu et al, 2023, International Journal of Immunopathology and Pharmacology CrossRef
14. Upregulation of CDC25B by transcription factor TEAD4 drives invasion and inhibits cisplatin sensitivity through cell adhesion in stomach adenocarcinoma
    Tao Zhang et al, 2024, Anti-Cancer Drugs CrossRef
15. Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling
    Brooke L. Brauer et al, 2023, Journal of Proteome Research CrossRef
16. α-Catenin acetylation is essential for its stability and blocks its tumor suppressor effects in breast cancer through Yap1
    Yuxi Yang et al, 2023, Cancer Gene Therapy CrossRef
17. Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer
    Sai Harshita Posani et al, 2024, The Journal of Steroid Biochemistry and Molecular Biology CrossRef